Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (91-100 of 6,821) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|May 1, 2012
Oncology trials gear up for high-throughput sequencingAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2016
Pharma pumps up anti-tau Alzheimer pipeline despite first Phase III failureAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2016
mRNA-based drug approaches Phase I milestoneAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2016
Leading microbiome-based therapeutic falters in Phase II trialAsher Mullard
Nursing Mirror and Midwives Journal|March 19, 2010
Medical progress through six years of warP ASHER
Nature Reviews. Drug Discovery|October 2, 2018
Industry advances landmark CRISPR candidate into the clinicAsher Mullard
Nature Reviews. Drug Discovery|May 31, 2018
FDA approves first-in-class SYK inhibitorAsher Mullard
Nature Reviews. Drug Discovery|May 31, 2018
On the origin of transformative drugsAsher Mullard
Nature Reviews. Drug Discovery|September 30, 2017
CETP inhibitors stumble onAsher Mullard
Nature Reviews. Drug Discovery|February 2, 2018
Pfizer exits neuroscienceAsher Mullard
Pageof 683

Showing results (91-100 of 6,821) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|May 1, 2012
Oncology trials gear up for high-throughput sequencingAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2016
Pharma pumps up anti-tau Alzheimer pipeline despite first Phase III failureAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2016
mRNA-based drug approaches Phase I milestoneAsher Mullard
Nature Reviews. Drug Discovery|August 31, 2016
Leading microbiome-based therapeutic falters in Phase II trialAsher Mullard
Nursing Mirror and Midwives Journal|March 19, 2010
Medical progress through six years of warP ASHER
Nature Reviews. Drug Discovery|October 2, 2018
Industry advances landmark CRISPR candidate into the clinicAsher Mullard
Nature Reviews. Drug Discovery|May 31, 2018
FDA approves first-in-class SYK inhibitorAsher Mullard
Nature Reviews. Drug Discovery|May 31, 2018
On the origin of transformative drugsAsher Mullard
Nature Reviews. Drug Discovery|September 30, 2017
CETP inhibitors stumble onAsher Mullard
Nature Reviews. Drug Discovery|February 2, 2018
Pfizer exits neuroscienceAsher Mullard
Pageof 683